Pontifax fund and Israeli institutional investors will profit from the US personalized cancer drug company's huge sale. Part of the technology was developed at the Weizmann Institute.
继续阅读 Globes English – Israeli investors profit from $11.9b Kite acquisition
"The level of responsibility for young people in the Israeli army trains them for entrepreneurship and they see startups as a way to follow the Jewish idea of Tikun Olam…
继续阅读 After Imperva And Mobileye, Here’s What’s Next For Israeli Startups